Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: MISCELLANEOUS

Precision ADM Quebec Inc. Invests into New Gatineau Manufacturing Facility to Produce and Distribute 8 Million CANSWABtm Nasopharyngeal Swabs per Month for Québec and Canada


GATINEAU, Quebec, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Precision ADM Québec Inc. ("PADM Quebec", "the Company") will invest more than $2 million in its new Gatineau facility to manufacture the largest domestic supply of CANSWABtm nasopharyngeal (NP) swabs for COVID-19 screening. At full operation, PADM Quebec will produce 8 million NP swabs per month for Quebec and Canada.

This investment in the Québec manufacturing ecosystem, combined with a network of Canadian suppliers capable of providing transport media enables PADM Québec to provide Canada with complete autonomy for the manufacturing of crucial screening test kits in the fight against COVID-19.

"The first wave of the pandemic made us realize that our dependence on other countries for screening and personal protective equipment was a matter of national security," says Martin Petrak, President and CEO. "This is why we have decided to invest heavily in the development of several innovative solutions for Canada's procurement of critical medical supplies."

The Gatineau plant will also have the mandate to manufacture other personal protective equipment designed by its team of engineers, including disposable level 1/2/3 procedure masks and Precision AIRtm reusable N95-level respirator masks specifically intended for healthcare and emergency services workers. Manufacturing equipment has already been installed and the Company expects to reach full production by early 2021. A high-throughput version of CANSWABtm is currently in final clinical trials by Québec physicians. This collaboration has allowed PADM Québec to manufacture the most comfortable NP swab product on the market with proven efficacy through an iterative design process and manufactured on automated digital manufacturing platforms.

The Gatineau plant will have a production capacity of more than 8 million swabs per month and will also have the mandate to manufacture the same test kits for export. The Company is in talks with several international distributors for the supply of additional millions of screening tests and masks.

About Précision ADM Québec Inc.
Precision ADM Quebec® is a medical device company and global engineering and manufacturing solutions provider that uses advanced manufacturing to manufacture components and devices for the medical, aerospace, and industrial sectors.

Contact :
Martin Lavoie
Senior Manager - Quebec and Ontario
Précision ADM Québec Inc.
[email protected]
819-230-7350


These press releases may also interest you

at 08:40
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that, further...

at 08:36
Sila Services, LLC is pleased to announce its acquisition of T-Mark Plumbing, Heating, Cooling & Electric, Western New York's leading home services company. Founded in Buffalo in 1998, T-Mark's reputation for reliability, responsiveness, and...

at 08:35
Omni Design Technologies, a leading provider of high-performance, low-power mixed-signal intellectual property (IP), today announced it has joined the Intel Foundry Accelerator IP Alliance. Members of this alliance collaborate with Intel Foundry to...

at 08:35
Pagaya Technologies intends to announce its first quarter 2024 earnings on May 9, 2024. A conference call to discuss those earnings will be held on the same day at 8:30 a.m. ET / 3:30 p.m. IDT. Details to register for the live webcast presentation...

at 08:35
Energy Vault Holdings, Inc. ("Energy Vault" or the "Company"), a leader in sustainable grid-scale energy storage solutions, announced today that the Company will host its inaugural Investor & Analyst Day on Thursday, May 9, 2024 in New York. The...

at 08:33
Prescient Healthcare Group, a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors ? Dr. Luke Solon and Debbie Allman ? to help shape and drive Prescient's global mission....



News published on and distributed by: